Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

There's been a major selloff in Euroapi S.A. (EPA:EAPI) shares in the week since it released its yearly report, with the stock down 41% to €4.00. Revenues came in at €1.0b, in line with estimates, while Euroapi reported a statutory loss of €2.02 per share, well short of prior analyst forecasts for a profit. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Euroapi after the latest results.

See our latest analysis for Euroapi

earnings-and-revenue-growth
ENXTPA:EAPI Earnings and Revenue Growth March 2nd 2024

Following last week's earnings report, Euroapi's five analysts are forecasting 2024 revenues to be €1.02b, approximately in line with the last 12 months. Euroapi is also expected to turn profitable, with statutory earnings of €0.19 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of €1.04b and earnings per share (EPS) of €0.18 in 2024. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates.

The consensus price target fell 14% to €7.20, suggesting the increase in earnings forecasts was not enough to offset other the analysts concerns. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Euroapi at €10.50 per share, while the most bearish prices it at €4.50. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Euroapi's past performance and to peers in the same industry. We would highlight that Euroapi's revenue growth is expected to slow, with the forecast 0.03% annualised growth rate until the end of 2024 being well below the historical 3.7% p.a. growth over the last three years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 4.7% per year. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Euroapi.

Advertisement

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Euroapi following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Euroapi's future valuation.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Euroapi going out to 2026, and you can see them free on our platform here.

Even so, be aware that Euroapi is showing 2 warning signs in our investment analysis , and 1 of those shouldn't be ignored...

Valuation is complex, but we're here to simplify it.

Discover if Euroapi might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ENXTPA:EAPI

Euroapi

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

DA
davidlsander
OPTH logo
davidlsander on Optimi Health ·

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Fair Value:US$1257.9% undervalued
5 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0328.6% undervalued
36 users have followed this narrative
3 users have commented on this narrative
12 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.527.2% undervalued
22 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.720.8% undervalued
47 users have followed this narrative
3 users have commented on this narrative
20 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
268A logo
AstrisCorporateAdvisory on Rigaku Holdings ·

Capitalizing on rising semiconductor complexity

Fair Value:JP¥2.52k14.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
UM
LUCK logo
UmarHashmi on Lucky Cement ·

Lucky Cement expected to bloom with 12% revenue growth

Fair Value:PK₨64029.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
DMET logo
RockeTeller on Denarius Metals ·

558% IRR Gold Project Already in Production, Colombia’s Next Major Producer

Fair Value:CA$110.1399.5% undervalued
26 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28020.0% undervalued
285 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.1% overvalued
147 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0942.2% undervalued
169 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative